Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L DEWEY

Showing results (441-450 of 460) with videos related to

Pageof 46
Sort By:
ACS Pharmacology & Translational Science|December 19, 2024
Discovery of 6α-Thiazolylcarboxamidonaltrexamine Derivative (NTZ) as a Potent and Central Nervous System Penetrant Opioid Receptor Modulator with Drug-like Properties for Potential Treatment of Opioid Use DisorderBoshi Huang, Hongguang Ma, Piyusha P Pagare, et al.
Nuclear Medicine and Biology|April 1, 1996
Opioid receptor imaging and displacement studies with [6-O-[11C] methyl]buprenorphine in baboon brainI Galynker, D J Schlyer, S L Dewey, et al.
Cell and Tissue Research|May 15, 2012
VACM-1/cul5 expression in vascular tissue in vivo is induced by water deprivation and its expression in vitro regulates aquaporin-1 concentrationsAlyssa E Johnson, Isabelle P Le, Bradley T Andresen, et al.
Synapse (New York, N.Y.)|November 19, 2008
Racemic gamma vinyl-GABA (R,S-GVG) blocks methamphetamine-triggered reinstatement of conditioned place preferenceAmy DeMarco, Reema M Dalal, Jessica Pai, et al.
ACS Chemical Neuroscience|February 14, 2019
Characterization of 17-Cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(indole-7-carboxamido)morphinan (NAN) as a Novel Opioid Receptor Modulator for Opioid Use Disorder TreatmentSamuel Obeng, Abdulmajeed Jali, Yi Zheng, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 3, 2002
Acute handling stress modulates methylphenidate-induced catecholamine overflow in the medial prefrontal cortexDouglas A Marsteller, Madina R Gerasimov, Wynne K Schiffer, et al.
Journal of Medicinal Chemistry|May 30, 2024
Systematic Structure-Activity Relationship Study of Nalfurafine Analogues toward Development of Potentially Nonaddictive Pain Management TreatmentsCelsey M St Onge, Piyusha P Pagare, Yi Zheng, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 18, 2007
PET studies of d-methamphetamine pharmacokinetics in primates: comparison with l-methamphetamine and ( --)-cocaineJoanna S Fowler, Carsten Kroll, Richard Ferrieri, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 8, 2006
Pharmacological characterization of novel water-soluble cannabinoidsBilly R Martin, Jenny L Wiley, Irina Beletskaya, et al.
Developmental Biology|March 23, 2024
Graded FGF activity patterns distinct cell types within the apical sensory organ of the sea anemone Nematostella vectensisKeith Z Sabin, Shiyuan Chen, Eric M Hill, et al.
Pageof 46

Showing results (441-450 of 460) with videos related to

Sort By:
Pageof 46
ACS Pharmacology & Translational Science|December 19, 2024
Discovery of 6α-Thiazolylcarboxamidonaltrexamine Derivative (NTZ) as a Potent and Central Nervous System Penetrant Opioid Receptor Modulator with Drug-like Properties for Potential Treatment of Opioid Use DisorderBoshi Huang, Hongguang Ma, Piyusha P Pagare, et al.
Nuclear Medicine and Biology|April 1, 1996
Opioid receptor imaging and displacement studies with [6-O-[11C] methyl]buprenorphine in baboon brainI Galynker, D J Schlyer, S L Dewey, et al.
Cell and Tissue Research|May 15, 2012
VACM-1/cul5 expression in vascular tissue in vivo is induced by water deprivation and its expression in vitro regulates aquaporin-1 concentrationsAlyssa E Johnson, Isabelle P Le, Bradley T Andresen, et al.
Synapse (New York, N.Y.)|November 19, 2008
Racemic gamma vinyl-GABA (R,S-GVG) blocks methamphetamine-triggered reinstatement of conditioned place preferenceAmy DeMarco, Reema M Dalal, Jessica Pai, et al.
ACS Chemical Neuroscience|February 14, 2019
Characterization of 17-Cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(indole-7-carboxamido)morphinan (NAN) as a Novel Opioid Receptor Modulator for Opioid Use Disorder TreatmentSamuel Obeng, Abdulmajeed Jali, Yi Zheng, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 3, 2002
Acute handling stress modulates methylphenidate-induced catecholamine overflow in the medial prefrontal cortexDouglas A Marsteller, Madina R Gerasimov, Wynne K Schiffer, et al.
Journal of Medicinal Chemistry|May 30, 2024
Systematic Structure-Activity Relationship Study of Nalfurafine Analogues toward Development of Potentially Nonaddictive Pain Management TreatmentsCelsey M St Onge, Piyusha P Pagare, Yi Zheng, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 18, 2007
PET studies of d-methamphetamine pharmacokinetics in primates: comparison with l-methamphetamine and ( --)-cocaineJoanna S Fowler, Carsten Kroll, Richard Ferrieri, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 8, 2006
Pharmacological characterization of novel water-soluble cannabinoidsBilly R Martin, Jenny L Wiley, Irina Beletskaya, et al.
Developmental Biology|March 23, 2024
Graded FGF activity patterns distinct cell types within the apical sensory organ of the sea anemone Nematostella vectensisKeith Z Sabin, Shiyuan Chen, Eric M Hill, et al.
Pageof 46